2-hydroxy-3-phenyl-1,4-naphthoquinone as
(0.0918 g, 92% yield).37
a
yellow solid
13 (a) B. Iglesias, D. Pen˜a, D. Pe´rez, E. Guitia´n and L. Castedo, Synlett,
2002, 486–488; (b) N. Atanes, S. Escudero, D. Pe´rez, E. Guitia´n and L.
Castedo, Tetrahedron Lett., 1998, 39, 3039–3040.
14 (a) E. R. Biehl, A. Razzuk, M. V. Jovanovic and S. P. Khanapure, J. Org.
Chem., 1986, 51, 5157–5160; (b) X. Y. Han, M. V. Jovanovic and E. R.
Biehl, J. Org. Chem., 1985, 50, 1334–1337; (c) H. Y. Xin and E. R. Biehl,
J. Org. Chem., 1983, 48, 4397–4399.
15 D. E. Brooks, L. D.-L. Lu and S. Masamune, Angew. Chem., Int. Ed.
Engl., 1979, 18, 72–74.
Acknowledgements
The authors gratefully acknowledge Pamela M. Tadross and Scott
C. Virgil for helpful discussions and experimental assistance. The
authors thank Abbott, Amgen, Boehringer-Ingelheim, Bristol-
Myers Squibb, Merck, Sigma-Aldrich and Caltech for generous
funding.
16 All carboxylic acid starting materials employed in Tables 2 and 3 are
commercially available.
17 For the first preparation of this compound, see: R. Nowicki and A.
Fabrycy, Chem. Heterocycl. Compd., 1976, 12, 910–914.
18 (a) S. Busato, D. C. Craig, Z. M. A. Judeh and R. W. Read,
Tetrahedron, 2003, 59, 461–472; (b) M. B. Andrus and B. B. V. S.
Sekhar, J. Heterocycl. Chem., 2001, 38, 1265–1271; (c) G. Chelucci,
A. Bacchi, D. Fabbri, A. Saba and F. Ulgheri, Tetrahedron Lett., 1999,
40, 553–556.
19 N. W. Alcock, J. M. Brown and D. I. Hulmes, Tetrahedron: Asymmetry,
1993, 4, 743–756.
20 (a) J. M. Brown, D. I. Hulmes and T. P. Layzell, J. Chem. Soc.,
Chem. Commun., 1993, 1673–1674; (b) E. Fernandez, K. Maeda, M. W.
Hooper and J. M. Brown, Chem.–Eur. J., 2000, 6, 1840–1846.
21 J. M. Brown, D. I. Hulmes and P. J. Guiry, Tetrahedron, 1994, 50,
4493–4506.
References
1 (a) The Way of Synthesis, ed. T. Hudlicky, and J. W. Reed,
Wiley-VCH, Weinheim, 2007; (b) H. Bienayme´, C. Hulme, G. Oddon
and P. Schmitt, Chem.–Eur. J., 2000, 6, 3321–3329; (c) Process
Chemistry in the Pharmaceutical Industry, ed. K. G. Gadamasetti,
Marcel Dekker, New York, 1999.
2 (a) Vitamins and Hormones, ed. G. Litwack, Academic Press, London,
2008, vol. 78.; (b) R. P. Verma, Anti-Cancer Agents Med. Chem., 2006,
6, 489–499; (c) M. Alvarez, and J. A. Joule, in Science of Synthesis, ed.
D. S. Black, Thieme, Stuttgart, 2005, vol. 15, pp. 839-906; (d) R. M.
Kanojia, O. W. Lever, Jr., J. B. Press, L. Williams, H. M. Werblood,
E. C. Giardino, R. Falotico and A. J. Tobia, J. Med. Chem., 1989, 32,
990–997; (e) R. M. Kanojia, J. B. Press, O. W. Lever, Jr., L. Williams,
J. J. McNally, A. J. Tobia, R. Falotico and J. B. Moore, Jr., J. Med.
Chem., 1988, 31, 1363–1368.
3 (a) A. Krasovskiy, V. Krasovskaya and P. Knochel, Angew. Chem.,
Int. Ed., 2006, 45, 2958–2961; (b) A. Tsuboyama, H. Iwawaki, M.
Furugori, T. Mukaide, J. Kamatani, S. Igawa, T. Moriyama, S. Miura,
T. Takiguchi, S. Okada, M. Hoshino and K. Ueno, J. Am. Chem. Soc.,
2003, 125, 12971–12979; (c) S. C. Tucker, J. M. Brown, J. Oakes and
D. Thornthwaite, Tetrahedron, 2001, 57, 2545–2554; (d) J.-M. Valk,
T. D. W. Claridge, J. M. Brown, D. Hibbs and M. B. Hursthouse,
Tetrahedron: Asymmetry, 1995, 6, 2597–2610; (e) T. R. Kelly, A. Garcia,
F. Lang, J. J. Walsh, K. V. Bhaskar, M. R. Boyd, R. Gotz, P. A. Keller,
R. Walker and G. Bringmann, Tetrahedron Lett., 1994, 35, 7621–7624;
(f) K. Tamao, S. Kodama, I. Nakajima and M. Kumada, Tetrahedron,
1982, 38, 3347–3354.
4 (a) K. M. Allan and B. M. Stoltz, J. Am. Chem. Soc., 2008, 130, 17270–
17271; (b) C. D. Gilmore, K. M. Allan and B. M. Stoltz, J. Am. Chem.
Soc., 2008, 130, 1558–1559.
5 U. K. Tambar and B. M. Stoltz, J. Am. Chem. Soc., 2005, 127, 5340–
5341.
6 U. K. Tambar, D. C. Ebner and B. M. Stoltz, J. Am. Chem. Soc., 2006,
128, 11752–11753.
7 (a) S. Krishnan, J. T. Bagdanoff, D. C. Ebner, Y. K. Ramtohul, U. K.
Tambar and B. M. Stoltz, J. Am. Chem. Soc., 2008, 130, 13745–13754;
(b) S. Krishnan and B. M. Stoltz, Tetrahedron Lett., 2007, 48, 7571–
7573; (c) Q. Liu, E. M. Ferreira and B. M. Stoltz, J. Org. Chem., 2007,
72, 7352–7358.
22 X. Li, L. Kong, Y. Gao and X. Wang, Tetrahedron Lett., 2007, 48,
3915–3917.
23 (a) D. Kalyani, A. R. Dick, W. Q. Anani and M. S. Sanford, Tetrahedron,
2006, 62, 11483–11498; (b) D. Kalyani, A. R. Dick, W. Q. Anani and
M. S. Sanford, Org. Lett., 2006, 8, 2523–2526; (c) A. R. Dick, K. L.
Hull and M. S. Sanford, J. Am. Chem. Soc., 2004, 126, 2300–2301.
24 K. Tani, D. C. Behenna, R. M. McFadden and B. M. Stoltz, Org. Lett.,
2007, 9, 2529–2531.
25 (a) T. Thaler, F. Geittner and P. Knochel, Synlett, 2007, 17, 2655–2658;
(b) C. W. Lim, O. Tissot, A. Mattison, M. W. Hooper, J. M. Brown,
A. R. Cowley, D. I. Hulmes and A. J. Blacker, Org. Process Res. Dev.,
2003, 7, 379–384.
26 Bentley et al. made a similar observation using methyl 2-(4,5-
dimethoxy-2-acetylphenyl)acetate and later optimized the reaction
for the formation of the hydroxynaphthoquinone in 53% yield using
aqueous sodium hydroxide. See ref. 8.
27 R. J. Anderson and M. S. Newman, J. Biol. Chem., 1933, 101, 773–
779.
28 A. M. Aguinaldo, J. A. Armstrong, J. R. Cannon, S. M. Colegate, M. F.
Comber, N. G. Marchant and M. V. Sargent, Aust. J. Chem., 1996, 49,
197–198.
29 For the first preparation of this compound, see: R. G. Cooke and W. R.
Owen, Aust. J. Chem., 1962, 15, 486–491.
30 For the first preparation of this compound, see: T. Zincke and A. Breuer,
Justus Liebigs Ann. Chem., 1884, 226, 22–60.
31 For the first preparation of this compound, see: G. Wurm and H.-J.
Gurka, Pharmazie, 1997, 10, 739–743.
32 For the first preparation of this compound, see: K. Kobayashi, T. Taki,
M. Kawakita, M. Uchida, O. Morikawa and H. Konishi, Heterocycles,
1999, 51, 349–354.
33 For the first preparation of this compound, see: S. Koulouri, E.
Malamidou-Xenikaki, S. Spyroudis and M. Tsanakopoulou, J. Org.
Chem., 2005, 70, 8780–8784.
34 For the first preparation of this compound, see: R. J. Anderson and
M. S. Newman, J. Biol. Chem., 1933, 103, 405–412.
35 For the first preparation of this compound, see: A. C. Baillie and R. H.
Thomson, J. Chem. Soc. C, 1966, 2184–2186.
8 H. R. Bentley, W. Dawson and F. S. Spring, J. Chem. Soc., 1952, 1763–
1768.
9 For the first preparation of this compound, see: B. Alpha, E. Anklam,
R. Deschenaux, J.-M. Lehn and M. Pietraskiewiez, Helv. Chim. Acta,
1988, 71, 1042–1052.
10 G. Tommasi, Gazz. Chim. Ital., 1920, 50, 263.
11 For the first preparation of this compound, see: R. M. Kanojia, J. B.
Press, O. W. Lever, Jr., L. Williams, J. J. McNally, A. J. Tobia, R. Falotico
and J. B. Moore, Jr., J. Med. Chem., 1988, 31, 1363–1368.
12 For the first preparation of this compound, see: F. Freeman, D. K.
Farquhar and R. L. Walker, J. Org. Chem., 1968, 33, 3648–3650.
36 D. C. Ebner, U. K. Tambar and B. M. Stoltz, Org. Synth., 2009, 86,
161–171.
37 See ESI for detailed spectroscopic data and experimental spectra.
4964 | Org. Biomol. Chem., 2009, 7, 4960–4964
This journal is
The Royal Society of Chemistry 2009
©